Article: Peptide Antagonist Reduces Orthotopic Tumors In Mice.(EMD 121974 reduces orthotopic brain tumors)

2001 MAR 13 - (NewsRx.com & NewsRx.net) --

by Sonia Nichols, staff medical writer -- A new peptide antagonist demonstrates substantial anti-angiogenic effects on orthotopic brain tumors transplanted into mice.

The antagonist, called EMD 121974, is effective for reducing orthotopic brain tumors, but not heterotopic brain tumors, according to researchers from two institutions in the U.S.

"Brain tumors are highly angiogenic, and their growth and spread depend on the generation of new blood vessels," said Tobey J. MacDonald, an investigator in the Department of Pediatrics at the University of Southern California Keck School of Medicine. MacDonald ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!